M Srougi Selected Research

Prostatic Neoplasms (Prostate Cancer)

3/2022	Additional activation of the AR gene may be involved in the development of the castration resistance phenotype in prostate cancer.
10/2003	[PSA and anthropometric measurements among Amazon Indians: an evaluation of the Parkatejê community].
7/2001	Comparison of positivity frequency of bcl-2 expression in prostate adenocarcinoma with low and high Gleason score.
7/2001	Intracavernous injection in the treatment of erectile dysfunction after radical prostatectomy: an observational study.
5/2001	Abnormal expression of MDM2 in prostate carcinoma.
3/2001	Urinary continence and pathological outcome after bladder neck preservation during radical retropubic prostatectomy: a randomized prospective trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Srougi Research Topics

Disease

6	Prostatic Neoplasms (Prostate Cancer) 03/2022 - 03/2001
4	Neoplasms (Cancer) 07/2001 - 12/2000
2	Erectile Dysfunction 09/2012 - 07/2001
2	Infections 12/2009 - 06/2008
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019
1	Overweight 03/2016
1	Obesity 03/2016
1	Varicocele 03/2016
1	Prune Belly Syndrome 10/2015
1	Urogenital Abnormalities 10/2015
1	Urethral Stricture 08/2014
1	Urinary Incontinence 09/2012
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 01/2012
1	Body Weight (Weight, Body) 01/2012
1	Delayed Graft Function 06/2011
1	Megacystis microcolon intestinal hypoperistalsis syndrome 06/2011
1	Hemorrhagic Cystitis 12/2009
1	Herpes Simplex 12/2009
1	Virus Diseases (Viral Diseases) 12/2009
1	Lymphoma (Lymphomas) 06/2008
1	Acquired Immunodeficiency Syndrome (AIDS) 06/2008
1	Toxoplasmosis 06/2008
1	Hemorrhage 11/2003
1	Carcinogenesis 05/2001

Drug/Important Bio-Agent (IBA)

2	Hormones (Hormone)IBA 03/2016 - 07/2001
2	Proteins (Proteins, Gene)FDA Link 07/2001 - 05/2001
1	Methotrexate (Mexate)FDA LinkGeneric 01/2019
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2019
1	Azathioprine (Imuran)FDA LinkGeneric 01/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2019
1	Prednisone (Sone)FDA LinkGeneric 01/2019
1	Testosterone (Sustanon)FDA Link 03/2016
1	CholesterolIBA 01/2012
1	CollagenIBA 01/2012
1	LDL CholesterolIBA 01/2012
1	CreatinineIBA 06/2011
1	SteroidsIBA 06/2008
1	Prostate-Specific Antigen (Semenogelase)IBA 10/2003
1	phentolamine drug combination papaverineIBA 07/2001
1	Alprostadil (Muse)FDA LinkGeneric 07/2001
1	Biomarkers (Surrogate Marker)IBA 07/2001
1	Apoptosis Regulatory ProteinsIBA 07/2001
1	DNA (Deoxyribonucleic Acid)IBA 12/2000
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 12/2000
1	ParaffinIBA 12/2000

Therapy/Procedure

5	Prostatectomy (Retropubic Prostatectomy) 09/2012 - 03/2001
1	Castration 03/2022
1	Abdominoplasty 10/2015
1	Stents 08/2014
1	Lasers (Laser) 06/2011
1	Kidney Transplantation 12/2009
1	Organ Transplantation 06/2008
1	Drug Therapy (Chemotherapy) 07/2001
1	Therapeutics 07/2001